Noradrenalină Tartrat Hypericum (Noradrenaline Tartrate)

Noradrenaline tartrate, the active ingredient in Noradrenalină Tartrat Hypericum, is a sympathomimetic (alpha‑adrenergic agonist) presented as an intravenous solution for intravenous use. It is employed to raise blood pressure in patients with acute hypotension, septic shock, cardiogenic shock, or cardiac arrest. GNH USA supplies Noradrenalină Tartrat Hypericum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Noradrenaline tartrate acts as a potent vasopressor in critical‑care settings, targeting severe hypotensive states. - Acute hypotension: restores systemic vascular resistance and improves perfusion pressure. - Septic shock: counteracts vasodilatory failure to maintain mean arterial pressure. - Cardiogenic shock: supports cardiac output by increasing afterload when needed. - Cardiac arrest: provides immediate pressor support during resuscitation efforts.

Adverse reactions may occur with intravenous administration of noradrenaline tartrate.

Common Side Effects: - Hypertension: excessive rise in blood pressure. - Tachycardia: increased heart rate due to reflex mechanisms. - Headache: pressure changes in cerebral vessels. - Peripheral ischemia: reduced blood flow to extremities. - Extravasation injury: local tissue damage if the infusion leaks.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Myocardial ischemia: reduced coronary perfusion from high afterload. - Tissue necrosis: severe extravasation leading to gangrene. - Severe hypertension crisis: dangerously high arterial pressure.

When using noradrenaline tartrate, clinicians should observe several safety measures. - Blood pressure monitoring: titrate infusion to maintain target MAP. - Cardiac rhythm observation: watch for arrhythmias, especially in patients with pre‑existing heart disease. - Dose titration: adjust slowly to avoid abrupt hypertension. - Extravasation risk: use central venous access whenever possible. - Peripheral vascular disease: use with caution due to risk of ischemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline tartrate can interact with several drug classes, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: additive pressor effect leading to severe hypertension. - Other vasopressors (e.g., phenylephrine): may cause excessive vasoconstriction.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt tachycardia but increase afterload. - Calcium channel blockers: can enhance hypotensive episodes if dose is reduced. - ACE inhibitors or ARBs: may alter vascular response, requiring careful titration.